Election 2017 - Party Policies - Drugs - Pharmaceutical Reform
27th May 17, 9:55am
by
Pharmaceutical Reform
Click here to return to the policy homepage.
Not yet available on their website.
- Support the independence of PHARMAC and ensure that it can prioritise public benefit over restrictive trade obligations.
- Reduce distorted demand for prescription pharmaceuticals by prohibiting directto-public marketing by drug companies.
- Read more here.
Not yet available on their website.
Not yet available on their website.
- A record $850 million for Pharmac in 2016/17, meaning it can fund more lifesaving drugs and treatments for more New Zealanders. Many of these medicines are cutting-edge and extremely expensive, putting them out of reach for many New Zealanders.
- Pharmac is now looking at funding new treatments for advanced melanoma, Hepatitis C, brain tumours and to help women cope with menopause.
- Read more here.
- Conduct a review of the efficiency and efficacy of Pharmac's operations and of the adequacy of pharmaceutical funding.
- Set up a separate pharmaceutical fund for sufferers of rare diseases administered separately to Pharmac.
- Read more here.
Not yet available on their website.
 |
 |
 |
 |
We welcome your comments below. If you are not already registered, please register to comment.
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.